Health5 sources
FDA Approves Generic HIV-Prevention Drug for Low-Income Countries
- The U.S. FDA has approved a generic version of lenacapavir, a twice-a-year shot for HIV prevention.
- This approval aims to make the drug more accessible in low-income countries.
- Lenacapavir is the world's only twice-a-year shot for HIV prevention.
- The approval has raised hopes for improved HIV prevention in low-income regions.
- The generic version is expected to be more affordable than the original drug.
Articles (5)
STAT·
STAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries
The Independent·
US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
WCVB Boston·
FDA approves generic version of HIV-prevention drug to be sold in low-income countries
Associated Press·
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
ABC News·
Approval of cheap version of HIV-prevention shot raises hopes in low-income countries